Notably, recent investigations have revealed an unfavorable prognostic association between overexpression of PPARG and certain cancer types (e.g., prostate cancer, esophageal cancer), particularly those linked to obesity [26, 27]. Here, PPARG is linked to obesity due to melanocortin 4 receptor deficiency.